- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
William Kevin Kelly, DO | Authors
Articles
Selecting Therapy for Patients with CRPC
December 19, 2013
Video
William Kevin Kelly, DO, professor of medical oncology and urology, Thomas Jefferson University, discusses the possibility of preselecting which castration-resistant prostate cancer (CRPC) patients will be sensitive to chemotherapy or hormone therapy.
The Role of Chemotherapy in Prostate Cancer
November 19, 2013
Video
William Kevin Kelly, DO, discusses the role of chemotherapy in castration-resistant prostate cancer.